MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals
Evelia Leal-Ugarte1, Melva Gutiérrez-Angulo, Nelly M Macías-Gómez
1Unidad Academica de Ciencias de la Salud y Technologia, Universidad Autonoma de Tamaulipas, Sendero Nacional km 3, Matamoros, Tamaulipas, Mexico, CP 87349.
Insights
The MDR1 C3435T polymorphism does not appear to increase the risk of childhood acute lymphoblastic leukemia (ALL) in Mexican children. Genetic variations in this gene are not a significant factor for ALL development in this population.
Area of Science:
- Genetics
- Pediatric Oncology
Background:
- The MDR1 gene plays a crucial role in drug transport.
- Polymorphisms in the MDR1 gene, such as C3435T, may influence susceptibility to various diseases, including cancers.
- Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy.
Purpose of the Study:
- To investigate the association between the MDR1 C3435T polymorphism and the risk of developing childhood ALL in a Mexican population.
- To compare genotype and allele frequencies between children with ALL and healthy controls.
Main Methods:
- Genotyping of 107 children with ALL and 111 healthy children for the MDR1 C3435T polymorphism.
- Utilizing the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for genotyping.
- Statistical analysis of genotype and allele frequencies.
Main Results:
- No significant differences in MDR1 C3435T allele or genotype frequencies were observed between Mexican children with ALL and healthy controls (p > 0.176 for alleles, p > 0.255 for genotypes).
- Allele frequencies in Mexican healthy subjects differed significantly when compared to other global populations, suggesting potential ethnic variations.
- The CT and TT genotypes were not found to be associated with an increased risk of childhood ALL in this cohort.
Conclusions:
- The MDR1 C3435T polymorphism is unlikely to be a risk factor for childhood ALL in the studied Mexican population.
- Observed differences in allele frequencies among healthy Mexican subjects and other populations warrant further investigation into genetic background diversity.
- Future research should explore other genetic or environmental factors contributing to childhood ALL in diverse ethnic groups.
Abstract:
To determine the influence of the MDR1 C3435T polymorphism on the development of childhood acute lymphoblastic leukemia (ALL), we studied 107 children with ALL and 111 healthy subjects. All subjects were genotyped for the C3435T polymorphism using the polymerase chain reaction-restriction fragment length polymorphism method. The genotype frequencies in the patients were 17% homozygous CC, 61% heterozygous CT, and 22% homozygous TT; in healthy individuals the genotype frequencies were 14% CC, 53% CT, and 33% TT. In patients with ALL the allele frequencies were 0.47 for the C allele and 0.53 for the T allele; in the healthy group these allele frequencies were 0.40 and 0.60 for the C and T alleles, respectively. No significant differences in allele frequency (p > 0.176) and genotype frequency (p > 0.255) were detected between the two groups. These findings suggest that the CT or TT genotype does not increase the risk for childhood ALL in Mexican patients. On the other hand, significant differences in allele frequencies were detected in the comparison of Mexican healthy subjects with other populations. Whether these differences are fortuitous or related to diverse genetic backgrounds remains to be elucidated.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
